BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8471428)

  • 1. Cellular accumulation of 18F-labelled boronophenylalanine depending on DNA synthesis and melanin incorporation: a double-tracer microautoradiographic study of B16 melanomas in vivo.
    Kubota R; Yamada S; Ishiwata K; Tada M; Ido T; Kubota K
    Br J Cancer; 1993 Apr; 67(4):701-5. PubMed ID: 8471428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine.
    Ishiwata K; Shiono M; Kubota K; Yoshino K; Hatazawa J; Ido T; Honda C; Ichihashi M; Mishima Y
    Melanoma Res; 1992 Sep; 2(3):171-9. PubMed ID: 1450671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Borono-2-[18F]fluoro-D,L-phenylalanine: a possible tracer for melanoma diagnosis with PET.
    Ishiwata K; Ido T; Honda C; Kawamura M; Ichihashi M; Mishima Y
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):311-8. PubMed ID: 1629021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active melanogenesis in non-S phase melanocytes in B16 melanomas in vivo investigated by double-tracer microautoradiography with 18F-fluorodopa and 3H-thymidine.
    Kubota R; Yamada S; Ishiwata K; Kubota K; Ido T
    Br J Cancer; 1992 Oct; 66(4):614-8. PubMed ID: 1419597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
    Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
    J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Borono-2-[18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography.
    Ishiwata K; Ido T; Kawamura M; Kubota K; Ichihashi M; Mishima Y
    Int J Rad Appl Instrum B; 1991; 18(7):745-51. PubMed ID: 1787083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective 2-[18F]fluorodopa uptake for melanogenesis in murine metastatic melanomas.
    Ishiwata K; Kubota K; Kubota R; Iwata R; Takahashi T; Ido T
    J Nucl Med; 1991 Jan; 32(1):95-101. PubMed ID: 1899113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-Borono-2-
    Ishiwata K
    Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution of boron concentration on melanoma-bearing hamsters after administration of p-, m-, o-boronophenylalanine.
    Hiratsuka J; Yoshino K; Kondoh H; Imajo Y; Mishima Y
    Jpn J Cancer Res; 2000 Apr; 91(4):446-50. PubMed ID: 10804294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET.
    Havu-Aurén K; Kiiski J; Lehtiö K; Eskola O; Kulvik M; Vuorinen V; Oikonen V; Vähätalo J; Jääskeläinen J; Minn H
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):87-94. PubMed ID: 16896669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive estimation of
    Yoshimoto M; Honda N; Kurihara H; Hiroi K; Nakamura S; Ito M; Shikano N; Itami J; Fujii H
    Cancer Sci; 2018 May; 109(5):1617-1626. PubMed ID: 29498142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
    J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective uptake of para-boronophenylalanine increases in amelanotic melanoma cells transfected by the tyrosinase gene.
    Hiratsuka J; Kondoh H; Tsuboi T; Yoshino K; Imajo Y; Mishima Y
    Melanoma Res; 2000 Jun; 10(3):297-302. PubMed ID: 10890385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics in melanoma-bearing mice of 5-dihydroxyboryl-6-propyl-2-thiouracil (BPTU), a candidate compound for boron neutron capture therapy.
    Verrijk R; Smolders IJ; Huiskamp R; Gavin PR; Philipp KH; Begg AC
    Br J Cancer; 1994 Apr; 69(4):641-7. PubMed ID: 8142252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular binding of carboranylalanine and some effects of boron neutron capture. Analysis of cultured melanoma B16 cells.
    Pettersson OA; Olsson P; Lindström P; Sjöberg S; Larsson BS; Carlsson J
    Acta Oncol; 1994; 33(6):685-91. PubMed ID: 7946449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Metabolically Stable Boron-Derived Tyrosine Serves as a Theranostic Agent for Positron Emission Tomography Guided Boron Neutron Capture Therapy.
    Li J; Shi Y; Zhang Z; Liu H; Lang L; Liu T; Chen X; Liu Z
    Bioconjug Chem; 2019 Nov; 30(11):2870-2878. PubMed ID: 31593447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boron uptake in normal melanocytes and melanoma cells and boron biodistribution study in mice bearing B16F10 melanoma for boron neutron capture therapy.
    Faião-Flores F; Coelho PR; Arruda-Neto JD; Camillo MA; Maria-Engler SS; Rici RE; Sarkis JE; Maria DA
    Radiat Environ Biophys; 2012 Aug; 51(3):319-29. PubMed ID: 22491822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma.
    Chen JC; Chang SM; Hsu FY; Wang HE; Liu RS
    Appl Radiat Isot; 2004 Nov; 61(5):887-91. PubMed ID: 15308163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I.
    Imahori Y; Ueda S; Ohmori Y; Sakae K; Kusuki T; Kobayashi T; Takagaki M; Ono K; Ido T; Fujii R
    Clin Cancer Res; 1998 Aug; 4(8):1825-32. PubMed ID: 9717808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of BPA uptake in clear cell sarcoma (CCS) in vitro and development of an in vivo model of CCS for BNCT studies.
    Fujimoto T; Andoh T; Sudo T; Fujita I; Imabori M; Moritake H; Sugimoto T; Sakuma Y; Takeuchi T; Sonobe H; Epstein AL; Akisue T; Kirihata M; Kurosaka M; Fukumori Y; Ichikawa H
    Appl Radiat Isot; 2011 Dec; 69(12):1713-6. PubMed ID: 21354804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.